Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO)
ROSA of North Dallas will offer state-of-the-art cancer treatmentservices, including intensity-modulated radiation therapy (IMRT) andimage-guided radiation therapy (IGRT) in the Dallas center. The joint ventureexpects to build on Landmark Radiation's legacy of providing high-qualitycancer care to the residents of the north Dallas area. Edward Gilbert, M.D.will serve as medical director for ROSA of North Dallas, and Dr. TimothyNichols will also continue to provide professional radiation oncology servicesat the facility.
Advertisement
Dr. Gilbert said, "We look forward to working with Ambulatory Services ofAmerica and Radiation Oncology Services of America to provide a full range ofradiation therapy services to patients in North Dallas. We are pleased tohave worked with Landmark Radiation to build the North Dallas center and lookforward to a long relationship with ASA and ROSA."
Timothy Martin, President and Chief Executive Officer of ASA, said, "Weare excited to expand our presence in the Dallas area and Texas generally.With the formation of ROSA of North Dallas, we now own and operate threeradiation oncology centers in Texas, with two in the Dallas metropolitanarea. We look forward to working with our new affiliated physicians toprovide high quality care to cancer patients."
Ambulatory Services of America, headquartered in Brentwood, Tennessee, isa diversified health care services company that provides alternative siteservices in partnership with physicians. ASA, through its primarysubsidiaries Radiation Oncology Services of America, Inc. and Renal Servicesof America, Inc. owns, operates and manages facilities providing radiationoncology services and dialysis services. After the acquisition, ASA will owninterests in and operate 41 dialysis centers and 13 radiation oncology centersin nine states and the territory of Guam. ASA also manages three otherdialysis centers.
SOURCE Ambulatory Services of America, Inc.
